Market Rank #6 · Evidence Tier A

Germany
Neuroscience Intelligence

Germany neuroscience intelligence: 461 indexed trials, 447 institutions, research score 50.64.

⚗
461Indexed trials
↗
94Recruiting
⌂
447Research institutions
◎
50.6Research score

Evidence profile

217Sponsors
30Disease areas
0Institution works
0Institution citations

Evidence signals

Research score 50.6 · Data confidence 100.00 · Evidence 50.6

Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.

Leading disease areas

parkinsons87trials
epilepsy60trials
alzheimers60trials
stroke41trials
other_neurology36trials
depression26trials
neuromuscular17trials
multiple_sclerosis16trials
adhd14trials
other_psychiatry13trials

Leading indexed sponsors

Merck Sharp & Dohme LLC23trials
Charite University, Berlin, Germany19trials
Hoffmann-La Roche16trials
University Hospital Tuebingen10trials
Ludwig-Maximilians - University of Munich10trials
UCB Pharma9trials
Novartis Pharmaceuticals9trials
University Hospital Muenster9trials
Boehringer Ingelheim9trials
Pfizer8trials